SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Summit Trail Advisors LLC

Summit Trail Advisors LLC decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,796 shares of the exchange traded fund’s stock after selling 2,752 shares during the period. Summit Trail Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $882,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. FMR LLC increased its position in shares of SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after acquiring an additional 830 shares during the period. Ameritas Advisory Services LLC grew its stake in SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after purchasing an additional 1,137 shares in the last quarter. Beaton Management Co. Inc. purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth about $212,000. Robinson Value Management Ltd. raised its position in SPDR S&P Biotech ETF by 1.2% in the 3rd quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock valued at $1,329,000 after purchasing an additional 155 shares in the last quarter. Finally, Hollow Brook Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 4.9% in the 3rd quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock valued at $2,141,000 after buying an additional 1,003 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $89.05 on Wednesday. The business has a 50-day simple moving average of $92.23 and a 200-day simple moving average of $96.30. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The company has a market cap of $6.79 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.